Neuroshield: In-Med Prognostics raises Rs 50 lakh from BIRAC

Published On 2019-01-10 04:00 GMT   |   Update On 2019-01-10 04:00 GMT

Pune: With an aim to bring affordable, accessible and evidence-based brain health diagnostic and prognostic tools to India and other emerging markets, Pune based startup, In-Med Prognostics is working on a software platform that will provide time-saving accurate Neuro analysis. The firm recently received Biotechnology Ignition Grant of Rs. 50 Lakh for a duration of 18 months from the Biotechnology Industry Research Assistance Council (BIRAC), Government of India.


The grant will be used to develop a cloud-based software platform that will label, visualize, and quantify the volumes of brain structures using 3D MRI images.


Startup incubator Venture Center in Pune is one of the partners and is associated with In-Med Prognostics for providing mentoring support and project monitoring.


Speaking about this grant, Rajesh Purushottam, Co-founder In-Med Prognostics, said, “Our proprietary software ‘Neuroshield’, addresses the need of the hour in neurology: accurate volumetric analysis of the brain and its structures. We will be leveraging deep learning algorithm and machine learning to provide time-saving accurate Neuro analysis which will aid in assessment and early detection of neurological disorders such as Dementia, Alzheimer’s and Parkinson’s at affordable prices. The proposed solution is to provide a self-explicative volumetric report within an analysis time of 20 minutes”.


After having been selected as one of Top 20 Global Science-based ventures in the prestigious Falling Walls Venture competition, Berlin, 2016, the team has made great strides in bringing the state-of-the-art knowledge and technology in neuroscience, image processing, artificial intelligence, and data analytics, to assist Indian physicians in accurately diagnosing various neurological disorders such as epilepsy and dementia. The company was founded by Rajesh Purushottam, Dr Latha Poonamallee, and Dr Al Curran.


The Biotechnology Ignition Grant (BIG) scheme is an initiative of Biotechnology Industry Research Assistance Council (BIRAC), Department of Biotechnology, Government of India. It is India’s largest early-stage biotech startup funding program that supports innovative ideas right from concept to proof-of-concept to advanced validation stage.


Also Read: Investors turn wary on Biogen, Eisai Alzheimer’s drug results

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News